LifeVantage Reports Q3 2026 Earnings with Revenue and Profit Declines
LifeVantage (LFVN) reported Q3 2026 earnings with a 25.2% decline in net revenue to $43.7 million, primarily due to lower sales of the MINDBODY GLP-1 system. The company also saw a drop in Americas revenue and a decrease in consultant counts. Gross profit margin and operating income also declined compared to the prior year.
Tickers: $LFVN
Topics: earnings expenses gross_profit net_income revenue